Загрузка...
Nivolumab plus ipilimumab in the treatment of advanced melanoma
Advanced melanoma has historically been a difficult disease to treat due to few effective systemic treatment options. However, over the past few years, scientific advancements in immune checkpoint inhibition have resulted in several novel approaches that have changed front-line management of advance...
Сохранить в:
| Опубликовано в: : | J Hematol Oncol |
|---|---|
| Главные авторы: | , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
BioMed Central
2015
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4628394/ https://ncbi.nlm.nih.gov/pubmed/26518223 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13045-015-0219-0 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|